Antitope Ltd. We are a Cambridge UK-based biotechnology company specializing in immunogenicity testing and the engineering of therapeutic antibodies/proteins to reduce immunogenicity. Our proprietary Composite Human AntibodyTM technology builds upon the previous pioneering work of its founders in the detection and removal of T cell epitopes in antibodies/proteins. We a privately-held company and has established multiple commercial relationships with leading biotechnology and pharmaceutical companies.